IVIM Health vs Lemonaid Health: Ratings, Pricing, and Protocols
Quick verdict: IVIM Health is a more verifiable option for clinician-guided, compounded GLP-1 care based on captured evidence of pricing, a free consultation, and dual 4.9-star ratings. Lemonaid Health has clinician review requirements but captured landing-page details including pricing and eligibility were not verified.
Explore IVIM Health’s free consult and GIFT75 offer
How IVIM Health vs Lemonaid Health differ at a glance
This comparison focuses on the most distinctive, supported differences: third-party ratings and credibility, pricing and promotional offers, compounded medication status and regulatory notes, protocol and outcome claims, and the level of verified provider detail for Lemonaid Health.
Third-party verification and trust signals
IVIM Health: Captured evidence shows IVIM with a 4.9-star rating on both Google and Trustpilot, presented as an unusually strong dual third-party verification. The source frames this as a key trust signal for patients who weigh external reviews.
Lemonaid Health: The captured affiliate landing page did not publish readable third-party ratings or verifiable review summaries. The comparison evidence for Lemonaid’s external ratings was not available.
Pricing, promotions, and upfront cost signals
IVIM Health: The source shows a promotional code GIFT75 for a free month membership and a no-obligation free consultation described as a $75 value. Published price points on the captured page include $75/mo for compounded semaglutide and $133/mo for compounded tirzepatide, plus a $74.99/mo program fee in some descriptions. The FAQ notes IVIM starts at $99 first month and $174/month ongoing, and that the GIFT75 code and free consult reduce upfront costs. These pricing and promo details are presented as captured landing-page evidence.
Lemonaid Health: Pricing and promotional details were not verified on the captured landing page. The source explicitly states current details were not published or could not be verified on the captured affiliate landing page.
See IVIM Health membership and consult details
Compounded medications and regulatory notes
IVIM Health: The source repeatedly notes IVIM prescribes compounded semaglutide and tirzepatide, and includes the regulatory note that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. The captured text warns that compounded products carry risks and are not appropriate for everyone.
Lemonaid Health: The captured evidence states treatment is available only when a licensed clinician determines it is medically appropriate, and that compounded medications, when offered, are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Other medication-specific approval or product details were not captured.
Protocol claims and outcome evidence
IVIM Health: The source attributes a proprietary GLP-1 ID protocol to IVIM, which the platform says can accelerate weight loss outcomes by up to 40 percent compared to standard GLP-1 protocols. The source also cites IVIM-published study summaries claiming average additional weight loss in retrospective observational analyses. The material explicitly qualifies these as IVIM protocol or internal data claims and not randomized head-to-head trials.
Lemonaid Health: No verified claims about protocol-specific outcomes or internal study results were captured on the affiliate landing page. The available evidence does not supply outcome comparisons for Lemonaid.
Comparison table: IVIM Health vs Lemonaid Health
| Criteria | IVIM Health | Lemonaid Health |
|---|---|---|
| Third-party ratings | 4.9 stars on Google and Trustpilot (captured) | Not published or not verified on captured page |
| Promotions and consult | Free month with code GIFT75; no-obligation free consult ($75 value) (captured) | Not verified on captured page |
| Pricing evidence | Captured price points: $75/mo semaglutide, $133/mo tirzepatide, FAQ notes $99 first month then $174/mo ongoing | Not verified on captured page |
| Medication type | Compounded semaglutide and tirzepatide; compounded products not FDA-approved (captured) | Compounded medications when offered are not FDA-approved; other details not captured |
| Protocol and outcomes | Proprietary GLP-1 ID protocol with up to 40 percent faster claim; internal retrospective data referenced and qualified | No protocol outcome details captured |
Availability, verification, and what is not supplied
The IVIM source supplies multiple captured details on rating, pricing, and promotional offers. For Lemonaid Health the captured affiliate landing page did not publish readable or verifiable pricing, eligibility, pharmacy, state coverage, renewal, or rating details. If you need confirmed Lemonaid specifics, the available evidence here does not provide them.
Check Lemonaid Health clinician-reviewed availability
Decision guide: Choose IVIM or Lemonaid
Choose IVIM Health if you prioritize documented third-party ratings, a captured promotional free month code, a no-obligation free consultation valued at $75, and a provider that publishes proprietary protocol claims with qualifying study summaries. The evidence supports IVIM’s pricing and promotional details and highlights compounded medication status and regulatory warnings.
Choose Lemonaid Health if you want to confirm eligibility, medication type, total cost, renewal terms, and state availability directly with Lemonaid before enrolling, because those details were not verified on the captured landing page.
Start IVIM Health enrollment and free consult
Contact Lemonaid Health to confirm eligibility
Final note: This article uses only the captured comparison evidence. All compounded medications referenced are described in the source as not FDA-approved and not reviewed by the FDA for safety, effectiveness, or quality. Individual results and availability may vary.